UB
JAZZ icon

UMB Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

UMB Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Buy
755
+30
+4% +$5.24K ﹤0.01% 813
2025
Q4 		$123K Buy
725
+81
+13% +$12.4K ﹤0.01% 856
2025
Q3 		$84.9K Buy
644
+41
+7% +$4.92K ﹤0.01% 939
2025
Q2 		$64K Sell
603
-70
-10% -$7.6K ﹤0.01% 1025
2025
Q1 		$83.6K Buy
673
+362
+116% +$47.2K ﹤0.01% 845
2024
Q4 		$38.3K Buy
311
+129
+71% +$15.2K ﹤0.01% 1020
2024
Q3 		$20.3K Buy
182
+145
+392% +$15.9K ﹤0.01% 1227
2024
Q2 		$3.95K Buy
37
+12
+48% +$1.32K ﹤0.01% 1519
2024
Q1 		$3.01K Buy
25
+18
+257% +$2.21K ﹤0.01% 1448
2023
Q4 		$861 Sell
7
-264
-97% -$32.9K ﹤0.01% 1541
2023
Q3 		$35.1K Hold
271
– – ﹤0.01% 919
2023
Q2 		$33.6K Hold
271
– – ﹤0.01% 948
2023
Q1 		$39.7K Buy
271
+112
+70% +$16.6K ﹤0.01% 903
2022
Q4 		$25K Buy
159
+152
+2,171% +$22.3K ﹤0.01% 1034
2022
Q3 		$1K Buy
+7
New +$1.06K ﹤0.01% 1671

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

UMB Bank's JAZZ Position: Q1 2026 in Review

UMB Bank increased its Jazz Pharmaceuticals (JAZZ) stake by 4.1% in Q1 2026, buying an estimated $5.24K and bringing the position to 755 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

UMB Bank first reported a position in JAZZ in Q3 2022 and has held it in 15 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • UMB Bank held 755 shares of Jazz Pharmaceuticals worth $143K as of Q1 2026.
  • UMB Bank bought 30 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.24K.
  • Jazz Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #813 holding.
  • UMB Bank first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.